INR 117.55
(-0.34%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 984.92 Million INR | 11.23% |
2022 | 885.46 Million INR | 0.73% |
2021 | 879.04 Million INR | 26.11% |
2020 | 697.06 Million INR | 34.12% |
2019 | 519.73 Million INR | -20.31% |
2018 | 652.19 Million INR | -5.38% |
2017 | 689.29 Million INR | 4.29% |
2016 | 660.93 Million INR | 10.49% |
2015 | 598.21 Million INR | -16.01% |
2014 | 712.25 Million INR | -0.48% |
2013 | 715.68 Million INR | -1.43% |
2012 | 726.05 Million INR | 29.65% |
2011 | 560.01 Million INR | 17.37% |
2010 | 477.12 Million INR | 18.6% |
2009 | 402.28 Million INR | 10.36% |
2008 | 364.52 Million INR | 26.9% |
2007 | 287.24 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q1 | - INR | -100.0% |
2023 FY | 984.92 Million INR | 11.23% |
2023 Q4 | 984.92 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 888.43 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 885.46 Million INR | 0.73% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 885.46 Million INR | 0.0% |
2022 Q2 | 774.61 Million INR | 0.0% |
2021 Q4 | 879.04 Million INR | 0.0% |
2021 FY | 879.04 Million INR | 26.11% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 748.81 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 Q4 | 697.06 Million INR | 0.0% |
2020 FY | 697.06 Million INR | 34.12% |
2020 Q2 | 482.91 Million INR | 0.0% |
2019 Q4 | 519.73 Million INR | 0.0% |
2019 FY | 519.73 Million INR | -20.31% |
2019 Q2 | 619.88 Million INR | 0.0% |
2018 FY | 652.19 Million INR | -5.38% |
2018 Q4 | 652.19 Million INR | 0.0% |
2018 Q2 | 583.73 Million INR | 0.0% |
2017 Q2 | 589.62 Million INR | 0.0% |
2017 FY | 689.29 Million INR | 4.29% |
2017 Q4 | 689.29 Million INR | 0.0% |
2016 Q4 | 660.93 Million INR | 0.0% |
2016 FY | 660.93 Million INR | 10.49% |
2016 Q2 | 535.12 Million INR | 0.0% |
2015 Q4 | 598.21 Million INR | 0.0% |
2015 FY | 598.21 Million INR | -16.01% |
2015 Q2 | 581.75 Million INR | 0.0% |
2014 Q2 | 702.46 Million INR | 0.0% |
2014 Q4 | 712.25 Million INR | 0.0% |
2014 FY | 712.25 Million INR | -0.48% |
2013 Q4 | 715.68 Million INR | 0.0% |
2013 FY | 715.68 Million INR | -1.43% |
2013 Q2 | 797.96 Million INR | 0.0% |
2012 Q4 | 726.05 Million INR | 0.0% |
2012 FY | 726.05 Million INR | 29.65% |
2011 Q4 | 560.01 Million INR | 0.0% |
2011 FY | 560.01 Million INR | 17.37% |
2010 FY | 477.12 Million INR | 18.6% |
2009 FY | 402.28 Million INR | 10.36% |
2008 FY | 364.52 Million INR | 26.9% |
2007 FY | 287.24 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Ajanta Pharma Limited | 352.8 Million INR | -179.174% |
Amrutanjan Health Care Limited | 17.28 Million INR | -5598.808% |
Sigachi Industries Limited | 1.43 Billion INR | 31.149% |
Bal Pharma Limited | 1.39 Billion INR | 29.471% |
Ind-Swift Laboratories Limited | 166.21 Million INR | -492.557% |
Medico Remedies Limited | 80.5 Million INR | -1123.449% |
Lasa Supergenerics Limited | 220.76 Million INR | -346.148% |
Venus Remedies Limited | 413.3 Million INR | -138.308% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -61.067% |
Alpa Laboratories Limited | 52.46 Million INR | -1777.299% |
Nectar Lifesciences Limited | 6.35 Billion INR | 84.502% |
Shilpa Medicare Limited | 9.37 Billion INR | 89.493% |
Aarti Drugs Limited | 5.64 Billion INR | 82.545% |
Lupin Limited | 29.21 Billion INR | 96.629% |
Aurobindo Pharma Limited | 66.47 Billion INR | 98.518% |
Zydus Lifesciences Limited | 8.04 Billion INR | 87.753% |
Windlas Biotech Limited | 36.41 Million INR | -2605.095% |
Suven Life Sciences Limited | 7.09 Million INR | -13778.047% |
Eris Lifesciences Limited | 27.81 Billion INR | 96.459% |
Valiant Laboratories Limited | 767.08 Million INR | -28.399% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 73.92% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 90.263% |
Ipca Laboratories Limited | 14.38 Billion INR | 93.152% |
Bliss GVS Pharma Limited | 998.4 Million INR | 1.35% |
Achyut Healthcare Limited | - INR | -Infinity% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 96.991% |
Bajaj HealthCare Limited | 3.32 Billion INR | 70.407% |
RPG Life Sciences Limited | - INR | -Infinity% |
Mankind Pharma Limited | 2.07 Billion INR | 52.459% |
Laurus Labs Limited | 25.77 Billion INR | 96.179% |
Piramal Pharma Limited | 47.1 Billion INR | 97.909% |
Syncom Formulations (India) Limited | 724.86 Million INR | -35.877% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 97.551% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 80.807% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 91.999% |
Unichem Laboratories Limited | 2.47 Billion INR | 60.207% |
Sequent Scientific Limited | 4.87 Billion INR | 79.804% |
Novartis India Limited | 69.7 Million INR | -1313.092% |
Wanbury Limited | 1.16 Billion INR | 15.446% |
Suven Pharmaceuticals Limited | 649.96 Million INR | -51.535% |
Wockhardt Limited | 23.56 Billion INR | 95.82% |
Themis Medicare Limited | 957.92 Million INR | -2.819% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -1001.583% |
Jubilant Pharmova Limited | 36.64 Billion INR | 97.312% |
Glenmark Life Sciences Limited | 171.48 Million INR | -474.367% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 95.08% |
Divi's Laboratories Limited | 30 Million INR | -3183.083% |
NATCO Pharma Limited | 3.71 Billion INR | 73.466% |
Gufic Biosciences Limited | 3.32 Billion INR | 70.415% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -200.649% |
Ind-Swift Limited | 10.13 Billion INR | 90.287% |
Procter & Gamble Health Limited | 95.6 Million INR | -930.256% |
FDC Limited | 205.18 Million INR | -380.018% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 49.081% |
Granules India Limited | 13.15 Billion INR | 92.51% |
Medicamen Biotech Limited | 308.17 Million INR | -219.602% |
Alkem Laboratories Limited | 14.18 Billion INR | 93.056% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -2041.979% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -22340.761% |
Brooks Laboratories Limited | 56.41 Million INR | -1645.733% |
Megasoft Limited | 1.47 Billion INR | 33.02% |
ZIM Laboratories Limited | 1.08 Billion INR | 9.494% |
Strides Pharma Science Limited | 25.16 Billion INR | 96.087% |
Neuland Laboratories Limited | 953.89 Million INR | -3.253% |
Morepen Laboratories Limited | 289.99 Million INR | -239.639% |
Hikal Limited | 8.17 Billion INR | 87.953% |
Indoco Remedies Limited | 6.71 Billion INR | 85.343% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 65.472% |
Kilitch Drugs (India) Limited | 316.46 Million INR | -211.227% |
Hester Biosciences Limited | 2.44 Billion INR | 59.697% |